Industry reports
Editor highlights

Publication dates

All regions

Arthritis Research Reports, April 2014

You might be interested in: rheumatoid arthritis, medical equipment, therapeutics, more »


 

1-20 of about 8 900 reports for Arthritis
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2014
  • by Global Data

... Is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world. Ankylosing spondylitis ...

Rheumatoid Arthritis Partnering 2009-2014

Rheumatoid Arthritis Partnering 2009-2014

  • $ 1 795
  • Industry report
  • March 2014
  • by Currentpartnering

... Where press releases do not. This data driven report contains over 200 links to online copies of actual rheumatoid arthritis deals and contract documents as submitted to the securities ...

Arthritis Partnering 2009-2014

Arthritis Partnering 2009-2014

  • $ 1 795
  • Industry report
  • March 2014
  • by Currentpartnering

... Links to online copies of actual arthritis deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of rheumatoid arthritis- the report reviews key pipeline products under drug profile section which includes, product description, mo ...

World Therapy: Arthritis – Pipeline Review, H1 2012

World Therapy: Arthritis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Therapeutic landscape of arthritis- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other ...

Guangzhou Pharmaceutical Company Limited (Symbol:600332) SWOT Analysis, Strategy, Revenues and Profits

Guangzhou Pharmaceutical Company Limited (Symbol:600332) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... Tea series, diabetes curing, cough and phlegm clearing, arthritis curing, gastric diseases curing and others. Guangzhou pharmaceutical company has 96 chain pharmacies, including 66 cai zhi lin chain ...

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • January 2014
  • by Global Markets Direct

... Of therapeutics under development for systemic juvenile idiopathic arthritis (sjia).- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain ...

Guangzhou Pharmaceutical Company Limited (600332) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Guangzhou Pharmaceutical Company Limited (600332) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Toxic, including herb tea series, diabetes curing, cough and phlegm clearing, arthritis curing, gastric diseases curing and others. Guangzhou pharmaceutical company has 96 chain pharmacies, including 66 cai zhi lin ...

Cellceutix Corporation (CTIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellceutix Corporation (CTIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Cancer agents targeting multiple tumors, cand targeting psoriasis cand targeting rheumatoid arthritis, cand with potential for indications of osteo-arthritis or asthma and others. It provides ...

Alterna LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alterna LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... And supplies therapeutic and over-the-counter medicines, and personal products. It offers products that are applied to cracked heels, to soften and smooth dry feet; topical arthritis and muscle pain relievers ...


» Read our Company Profiles

2 Companies for Arthritis

Johnson and Johnson

United States

Novartis Inc.

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.